These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 34113343)
21. Schistosoma mansoni tegument protein Sm29 is able to induce a Th1-type of immune response and protection against parasite infection. Cardoso FC; Macedo GC; Gava E; Kitten GT; Mati VL; de Melo AL; Caliari MV; Almeida GT; Venancio TM; Verjovski-Almeida S; Oliveira SC PLoS Negl Trop Dis; 2008 Oct; 2(10):e308. PubMed ID: 18827884 [TBL] [Abstract][Full Text] [Related]
22. Protection against Schistosoma haematobium infection in hamsters by immunization with Schistosoma mansoni gut-derived cysteine peptidases, SmCB1 and SmCL3. Tallima H; Abou El Dahab M; Kareem S; Dalton JP; El Ridi R Vaccine; 2017 Dec; 35(50):6977-6983. PubMed ID: 29122387 [TBL] [Abstract][Full Text] [Related]
23. Adult schistosome cDNA libraries as a source of antigens for the study of experimental and human schistosomiasis. Knight M; Simpson AJ; Bickle Q; Hagan P; Moloney A; Wilkins A; Smithers SR Mol Biochem Parasitol; 1986 Feb; 18(2):235-53. PubMed ID: 2938004 [TBL] [Abstract][Full Text] [Related]
24. Safety and immunogenicity of rSh28GST antigen in humans: phase 1 randomized clinical study of a vaccine candidate against urinary schistosomiasis. Riveau G; Deplanque D; Remoué F; Schacht AM; Vodougnon H; Capron M; Thiry M; Martial J; Libersa C; Capron A PLoS Negl Trop Dis; 2012; 6(7):e1704. PubMed ID: 22802974 [TBL] [Abstract][Full Text] [Related]
25. Predicted impact of mass drug administration on the development of protective immunity against Schistosoma haematobium. Mitchell KM; Mutapi F; Mduluza T; Midzi N; Savill NJ; Woolhouse ME PLoS Negl Trop Dis; 2014; 8(7):e3059. PubMed ID: 25079601 [TBL] [Abstract][Full Text] [Related]
26. Antibody responses in schistosomiasis haematobium in Somalia. Relation to age and infection intensity. Hagi H; Huldt G; Loftenius A; Schröder H Ann Trop Med Parasitol; 1990 Apr; 84(2):171-9. PubMed ID: 2116776 [TBL] [Abstract][Full Text] [Related]
27. Human IgE response to the Schistosoma haematobium 22.6 kDa antigen. Fitzsimmons CM; Stewart TJ; Hoffmann KF; Grogan JL; Yazdanbakhsh M; Dunne DW Parasite Immunol; 2004; 26(8-9):371-6. PubMed ID: 15679635 [TBL] [Abstract][Full Text] [Related]
28. Human Schistosoma haematobium antifecundity immunity is dependent on transmission intensity and associated with immunoglobulin G1 to worm-derived antigens. Wilson S; Jones FM; van Dam GJ; Corstjens PL; Riveau G; Fitzsimmons CM; Sacko M; Vennervald BJ; Dunne DW J Infect Dis; 2014 Dec; 210(12):2009-16. PubMed ID: 25001462 [TBL] [Abstract][Full Text] [Related]
29. Immunomics-guided discovery of serum and urine antibodies for diagnosing urogenital schistosomiasis: a biomarker identification study. Pearson MS; Tedla BA; Mekonnen GG; Proietti C; Becker L; Nakajima R; Jasinskas A; Doolan DL; Amoah AS; Knopp S; Rollinson D; Ali SM; Kabole F; Hokke CH; Adegnika AA; Field MA; van Dam G; Corstjens PLAM; Mduluza T; Mutapi F; Oeuvray C; Greco B; Chaiyadet S; Laha T; Cai P; McManus DP; Bottazzi ME; Felgner PL; Sotillo J; Loukas A Lancet Microbe; 2021 Nov; 2(11):e617-e626. PubMed ID: 34977830 [TBL] [Abstract][Full Text] [Related]
30. A recombinant protein from Schistosoma mansoni useful for the detection of S. mansoni and Schistosoma haematobium antibodies. Hancock K; Mohamed YB; Haichou X; Noh J; Dotson EM; Tsang VC J Parasitol; 1997 Aug; 83(4):612-8. PubMed ID: 9267400 [TBL] [Abstract][Full Text] [Related]
31. Human IgE, IgG subclass, and IgM responses to worm and egg antigens in schistosomiasis haematobium: a 12-month study of reinfection in Cameroonian children. Naus CW; van Dam GJ; Kremsner PG; Krijger FW; Deelder AM Clin Infect Dis; 1998 May; 26(5):1142-7. PubMed ID: 9597243 [TBL] [Abstract][Full Text] [Related]
32. Characterisation of tetraspanins from Schistosoma haematobium and evaluation of their potential as novel diagnostic markers. Mekonnen GG; Tedla BA; Pearson MS; Becker L; Field M; Amoah AS; van Dam G; Corstjens PLAM; Mduluza T; Mutapi F; Loukas A; Sotillo J PLoS Negl Trop Dis; 2022 Jan; 16(1):e0010151. PubMed ID: 35073344 [TBL] [Abstract][Full Text] [Related]
33. Current status of vaccines for schistosomiasis. McManus DP; Loukas A Clin Microbiol Rev; 2008 Jan; 21(1):225-42. PubMed ID: 18202444 [TBL] [Abstract][Full Text] [Related]
35. Detection of circulating antigens in patients with active Schistosoma haematobium infection. Hassan MM; Medhat A; Makhlouf MM; Shata T; Nafeh MA; Osman OA; Deaf EA; Galal N; Fouad YM Am J Trop Med Hyg; 1998 Aug; 59(2):295-301. PubMed ID: 9715950 [TBL] [Abstract][Full Text] [Related]
36. Tandem repeat recombinant proteins as potential antigens for the sero-diagnosis of Schistosoma mansoni infection. Kalenda YD; Kato K; Goto Y; Fujii Y; Hamano S Parasitol Int; 2015 Dec; 64(6):503-12. PubMed ID: 26148816 [TBL] [Abstract][Full Text] [Related]
37. Glycan Microarray-Assisted Identification of IgG Subclass Targets in Schistosomiasis. Yang YYM; van Diepen A; Brzezicka K; Reichardt NC; Hokke CH Front Immunol; 2018; 9():2331. PubMed ID: 30356796 [TBL] [Abstract][Full Text] [Related]
38. Screening diagnostic candidates for schistosomiasis from tegument proteins of adult Schistosoma japonicum using an immunoproteomic approach. Zhang M; Fu Z; Li C; Han Y; Cao X; Han H; Liu Y; Lu K; Hong Y; Lin J PLoS Negl Trop Dis; 2015 Feb; 9(2):e0003454. PubMed ID: 25706299 [TBL] [Abstract][Full Text] [Related]
40. Use of monoclonal antibodies prepared against Schistosoma mansoni hatching fluid antigens for demonstration of Schistosoma haematobium circulating egg antigens in urine. Nibbeling HA; Kahama AI; Van Zeyl RJ; Deelder AM Am J Trop Med Hyg; 1998 May; 58(5):543-50. PubMed ID: 9598438 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]